Bronchopulmonary Dysplasia in Preterm Infants: Pathophysiology and Management Strategies

Author： Carl T. DAngio William M. Maniscalco

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.6, Iss.5, 2004-01, pp. : 303-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Bronchopulmonary Dysplasia in Infants: Guidelines for Corticosteroid Use

By Grier David G. Halliday Henry L.

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 15-29

Adis International

Access to resources Recommend Favorite

Vitamin A in Prevention of Bronchopulmonary Dysplasia

Current Pharmaceutical Design, Vol. 18, Iss. 21, 2012-05 ,pp. : 3101-3113

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy for bronchopulmonary dysplasia in premature infants focuses on reducing the effects of oxygen toxicity and mechanical ventilation

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

Hypertension in Pregnancy: Pathophysiology & Management Strategies

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2567-2579

Bentham Science Publishers

Access to resources Recommend Favorite

Current Perspectives on the Prevention and Management of Chronic Lung Disease in Preterm Infants

By Shah P.S.

Pediatric Drugs, Vol. 5, Iss. 7, 2003-01 ,pp. : 463-480

Adis International

Access to resources Recommend Favorite